Abstract:In the crystal of the title compound, 2C(9)H(8)NO(+).C4H2-Br2O42-. 2C(4)H(4)Br(2)O(4), the dibromosuccinate dianion and dibromosuccinic acid molecules each lie on an inversion center. They interact via hydrogen bonding. The hydroxy-quinolinium cations are hydrogen bonded to both the dibromosuccinate anion and dibromosuccinic acid molecules. The overlapped arrangement and short face-to-face distance of 3.431 ( 17) Angstrom indicate the existence of pi-pi stacking between hydroxyquinolinium rings in the crystal structure.

8-(4-Nitrobenzyloxy)quinoline

8-Hydroxyquinolinium–dibromosuccinate–dibromosuccinic Acid (2/1/2)

4-(Pyridin-2-yl)-1,3-dithiol-2-one.

(S)-Ethyl 2-[4-(6-Chloroquinoxalin-2-yloxy)phenoxy]propanoate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

2-(4,5-Dihydro-1,3-oxazol-2-yl)quinoline

3-Benzoylmethylene-1-methyl-3,4-dihydroquinoxalin-2(1h)-one

8-[N-(Tert-Butoxycarbonyl)-L-Glycyl]-Quinolin-8-Amine

Ethyl 4-(4-Chloro-phen-yl)-2-methyl-5-oxo-5,6,7,8-tetra-hydro-quinoline-3-carboxyl-ate.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

3-Ethylsulfonyl-2-phenylquinoxaline 1,4-Dioxide

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

2,3-Bis(4-ethoxy-phen-yl)quinoxaline.

12-Benzoyl-2-methyl-naphtho-[2,3-b]indolizine-6,11-dione.

<i>N</i>-(8-Quinolyl)pyridine-2-carboxamide

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

4-(2-Chloro-4-nitrophenoxy)-n-[2-(4,6-dimethoxypyrimidin-2-yloxy)benzyl]aniline

8-Benzyl-5,7-bis(benzyloxy)-4h-benzopyran-4-one

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

8,9-Diphenylimidazo[1,2-c]quinazoline